PriceTargets.com logo

4basebio - 4BB Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: GBX 1,600
  • Forecasted Upside: 200.19%
  • Number of Analysts: 1
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 1 Buy Ratings
  • 0 Strong Buy Ratings
GBX 533 As of 06/3/2026 12:58 PM ET
▼ -17 (-3.09%)

This chart shows the closing price for 4BB by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New 4basebio Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for 4BB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for 4BB

Analyst Price Target is GBX 1,600
▲ +200.19% Upside Potential
This price target is based on 1 analysts offering 12 month price targets for 4basebio in the last 3 months. The average price target is GBX 1,600, with a high forecast of GBX 1,600 and a low forecast of GBX 1,600. The average price target represents a 200.19% upside from the last price of GBX 533.

This chart shows the closing price for 4BB for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is Buy

The current consensus among 1 investment analysts is to buy stock in 4basebio.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/10/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/10/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/8/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/6/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/5/2025
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/5/2026
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
5/4/2026
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/3/2026

Latest Recommendations

  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
10/2/2025Royal Bank Of CanadaReiterated RatingOutperformGBX 1,600
3/13/2025Royal Bank Of CanadaReiterated RatingOutperformGBX 1,600
(Data available from 6/3/2021 forward)

News Sentiment Rating

0.51 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/5/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/5/2025
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/4/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/3/2026
  • 3 very positive mentions
  • 6 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/5/2026
  • 1 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/4/2026
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
5/4/2026
  • 3 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/3/2026

Current Sentiment

  • 3 very positive mentions
  • 8 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

4basebio logo
4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients. Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.
Read More

Today's Range

Now: GBX 533
Low: 533
High: 575

50 Day Range

MA: GBX 494.47
Low: 420
High: 550

52 Week Range

Now: GBX 533
Low: 420
High: 1,150

Volume

136 shs

Average Volume

1,665 shs

Market Capitalization

£82.54 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.09

Frequently Asked Questions

What sell-side analysts currently cover shares of 4basebio?

The following sell-side analysts have issued research reports on 4basebio in the last year: Royal Bank Of Canada.
View the latest analyst ratings for 4BB.

What is the current price target for 4basebio?

0 Wall Street analysts have set twelve-month price targets for 4basebio in the last year. Their average twelve-month price target is GBX 1,600, suggesting a possible upside of 200.2%. Royal Bank Of Canada has the highest price target set, predicting 4BB will reach GBX 1,600 in the next twelve months. Royal Bank Of Canada has the lowest price target set, forecasting a price of GBX 1,600 for 4basebio in the next year.
View the latest price targets for 4BB.

What is the current consensus analyst rating for 4basebio?

4basebio currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe 4BB will outperform the market and that investors should add to their positions of 4basebio.
View the latest ratings for 4BB.

What other companies compete with 4basebio?

Other companies that are similar to 4basebio include Horizon Discovery Group plc (HZD.L), Scancell, Verona Pharma plc (VRP.L), BTG and Arix Bioscience. Learn More about companies similar to 4basebio.

How do I contact 4basebio's investor relations team?

4basebio's physical mailing address is 25 Norman Way, Over, Cambridge CB24 5QE, United Kingdom. The company's listed phone number is 44 1223 967 943. The official website for 4basebio is www.4basebio.com. Learn More about contacing 4basebio investor relations.